These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Ocular penetration and hypotensive activity of the topically applied carbonic anhydrase inhibitor L-645,151. Author: Bar-Ilan A, Pessah NI, Maren TH. Journal: J Ocul Pharmacol; 1986; 2(2):109-20. PubMed ID: 3503100. Abstract: The effects of the locally active carbonic anhydrase inhibitor L-645,151 on intraocular pressure (IOP), and aqueous humor flow were studied in normotensive albino rabbits, and correlated with the distribution of its hydrolysis product (L-643,799) in ocular tissues. The L-645,151 was given as a suspension in 1% hydroxyethylcellulose, in single drops (50 microliter) of concentrations ranging from 0.06 to 2%. The ocular hypotensive effect showed a distinct dose dependent pattern. At the highest dose, the reduction of pressure was 2.2 +/- 0.4 mmHg (n = 9). Aqueous humor flow was estimated by the IOP recovery rate assay and the changes in ascorbate concentration in aqueous humor. The relative changes in aqueous humor flow displayed a dose dependent pattern. At the highest dose there was a 26-22% decrease, similar to that reported for rabbits in which IOP was raised by intraocular treatment with alpha-chymotrypsin. The concentrations of L-643,799 in ocular tissues were dose related. Representative distribution (microM) for the 2% concentration at peak (1 hr) effect was cornea:290; anterior aqueous 46; posterior aqueous 10; iris + ciliary body 26. The apparent elimination rate constants (A) were: 0.20, 0.19, 0.23 and 0.13 hr-1 respectively. The factors that contribute to the observed high ocular hypotensive potency of L-645,151 include: high lipid solubility of the prodrug; reduced lipid solubility of the drug L-643,799, and accumulation in the cornea; high inhibitory activity against carbonic anhydrase.[Abstract] [Full Text] [Related] [New Search]